1Pankow JS, et al. Family history of coronary heart disease and hemostatic variables in middle - aged adults. Atherosclerosis Risk in Communities Investigators and Family Heart Study Research Group.Thromb - Haemost, 1997, 77(1): 87.
2Lauer RM. Role of family history and family testing in cardiovascular risk assessment. Am J Med, 1999,107(2A): 14S.
4Giannini SD, et al. First - degree kinship with young coronary artery disease patients markedly increases lipid - level disorders in asymptomatic hypertensives. J Cardiovasc Risk, 1998, 5(3): 141.
5Silberberg JS, et al. Correction for biases in a population - based study of family history and coronary heart disease. The Newcastle Family History Study I. Am J Epidemiol, 1998, 147(12):1123.
6Gazzaruso C, et al. Genetics and cardiovascular risk: a role for apolipoprotein(a) polymorphism. Cardiologia, 1999,44(4) :347.
7Hopkins PN, et al. Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease:results from the NHLBI Family Heart Study. Atherosclerosis, 1998,141(2) :333.
7Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults [ J ]. Circulation, 2004,110(10) : 1245 - 1250.
9Zimmet P, Boyko EJ, Collier GR, et al. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players[J]. Ann NY Acad Sci, 1999,892: 25-44.
10Pater C. The current status of primary prevention in coronary heart disease[J]. Curr Control Trials Cardiovasc Med, 2001,2:24-27.
